Gastroenterology

Gastroenterology

Volume 124, Issue 1, January 2003, Pages 248-250
Gastroenterology

Editorials
Defining nonalcoholic fatty liver disease: Implications for epidemiologic studies,☆☆

https://doi.org/10.1053/gast.2003.50032Get rights and content

Abstract

GASTROENTEROLOGY 2003;124:248-250

Cited by (165)

  • Prediction of fatty liver disease using machine learning algorithms

    2019, Computer Methods and Programs in Biomedicine
    Citation Excerpt :

    Additionally, a significant amount of studies described that FLD patients were asymptomatic, and pointed out specific cause of fatty liver disease. They mentioned that elevation of circulatory concentrations biomarkers such as serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT)are mainly responsible for hepatic damage [26,27]. Recently, several studies have reported classification results to correctly identify fatty liver patients and non-fatty liver patients.

  • Nonalcoholic fatty liver disease

    2018, Practical Hepatic Pathology: A Diagnostic Approach: Second Edition
View all citing articles on Scopus

Address requests for reprints to: Anna Mae Diehl, M. D., Departments of Medicine and Epidemiology, The Johns Hopkins University Schools of Medicine and Public Health Baltimore, 720 Rutland Street, 912 Ross Building, Maryland 21205. e-mail: [email protected]; fax: (410) 955-9677.

☆☆

Dr. Diehl is a consultant to the FDA panel reviewing TZDs manufactured by Takeda, is on the speakers bureau for Ascam Scandipharm, and is a consultant for metabasis insulin sensitizer.

View full text